Press Release: Lungpacer : Lungpacer Medical Announces Premarket Approval for AeroPace System
AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy for quicker patient liberation from mechanical ventilation AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy for quicker patient liberation from mechanical ventilation
Read full article »
Lungpacer is a Canada-based medical device company that develops and commercializes intravenous catheter-based phrenic-nerve-pacing systems for the healthcare sector.
Read more